
- /
- Supported exchanges
- / US
- / MDDVF.PINK
Medical Developments International Limited (MDDVF PINK) stock market data APIs
Medical Developments International Limited Financial Data Overview
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. The company was founded in 1972 and is headquartered in Scoresby, Australia.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Medical Developments International Limited data using free add-ons & libraries
Get Medical Developments International Limited Fundamental Data
Medical Developments International Limited Fundamental data includes:
- Net Revenue: 38 054 K
- EBITDA: 226 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Medical Developments International Limited Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: NaN
Get Medical Developments International Limited End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Medical Developments International Limited News

Bullish Medical Developments International Limited (ASX:MVP) insiders filled their treasuries with AU$1.7m worth of stock over last year
Multiple insiders secured a larger position in Medical Developments International Limited (ASX:MVP) shares over the last 12 months. This is reassuring as this suggests that insiders have increased opt...


Medical Developments International (ASX:MVP) shareholders have endured a 52% loss from investing in the stock five years ago
Statistically speaking, long term investing is a profitable endeavour. But unfortunately, some companies simply don't succeed. To wit, the Medical Developments International Limited (ASX:MVP) share pr...

We're Hopeful That Medical Developments International (ASX:MVP) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenu...

The Medical Developments International Limited (ASX:MVP) Analysts Have Been Trimming Their Sales Forecasts
Market forces rained on the parade of Medical Developments International Limited (ASX:MVP) shareholders today, when the analysts downgraded their forecasts for this year. This report focused on revenu...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.